Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema

BACKGROUND/AIMS: The RELIGHT clinical trial used an individualised treatment regimen of ranibizumab to treat diabetic macular oedema (DMO). We report findings from two patient-reported outcome instruments. METHODS: The National Eye Institute Visual Function Questionnaire (NEI-VFQ) was administered b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Open Ophthalmol
Main Authors: Chakravarthy, Usha, Pearce, Ian, Banerjee, Sanjiv, Burton, Benjamin J L, Downey, Louise, Gale, Richard, Patel, Jignesh, Patra, Sudeshna, Sivaprasad, Sobha, Stevenson, Michael, Lupton, Susanne
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528749/
https://ncbi.nlm.nih.gov/pubmed/31179389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2018-000226
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker